CTRI’s Wallace Named to Medical/Scientific Board

Mark Wallace

CTRI Clinical Research Director Mark Wallace

An article about CTRI Clinical Research Director Mark Wallace, "Inergetics Appoints Mark Wallace, MD as Member of Medical/Scientific Advisory Board for Development of CBD-Based Nutritional Supplements," was published in the March 26 edition of the Wall Street Journal. Dr. Wallace's role on the board will be to "guide the formulation of a proprietary line of natural cannabidiol (CBD)-based nutritional supplements" the company is developing with Terra Tech Corp, according to the news announcement. Dr. Wallace, an anesthesiologist, is an expert in pain management.